2-Chloropyridine

2-Chloropyridine

SCHEMBL5751999

Clc1ccccn1.[Zn]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108484492-A Niacinamide synthesizes the technical study of 2,3,6- trichloropyridines 安徽国星生物化学有限公司 2018-09-04 CN disclosed
CN-107815702-A A kind of preparation method of 2,3,5 trichloropyridine 浙江工业大学 2018-03-20 CN disclosed
CN-102964294-A Pyridyl inhibitors of hedgehog signalling GENENTECH INC 2013-03-13 CN disclosed
CN-102083822-A Pyridyl inhibitors of HEDGEHOG signalling GENENTECH INC 2011-06-01 CN disclosed
CN-101772508-A Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex SUMITOMO CHEMICAL CO 2010-07-07 CN disclosed
CN-101072755-A Pyridyl inhibitors of Hedgehog signaling GENENTECH INC (US) 2007-11-14 CN disclosed
EP-1387839-B1 PROCESS FOR THE PRODUCTION OF QUINAZOLINES PFIZER LTD (GB) 2006-03-08 EP disclosed
EP-1430068-A1 6-O-CARBAMATE-11,12-LACTO-KETOLIDE ANTIMICROBIALS Ortho-Mcneil Pharmaceutical, Inc. (US) 2004-06-23 EP disclosed
WO-2004050624-A1 SUBSTITUTED 1H-PYRIDINE-2-ONE DERIVATIVES C & C RESEARCH LABORATORIES (KR) 2004-06-17 WO disclosed
US-6734303-B2 THERAPY FOR BENIGN PROSTATIC HYPERPLASIA PFIZER INC. 2004-05-11 US disclosed
US-6713455-B2 A BICYCLIC HETEROAROMATIC COMPOUND CONTAINING TWO KETO, TWO ESTER, A CARBAMATE GROUPS AND A METHYL, HYDROXY AND AMINE SUBSTITUTED OXYPYRAN RING; USEFUL ANTIBACTERIAL AGENT FOR TREATING PNEUMONIA, SKIN, SOFT TISSUE AND BONE INFECTIONS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-03-30 US disclosed
EP-1387839-A1 PROCESS FOR THE PRODUCTION OF QUINAZOLINES Pfizer Limited (GB) 2004-02-11 EP disclosed
US-20030125267-A1 6-O-carbamate-11,12-lacto-ketolide antimicrobials ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-07-03 US disclosed
WO-2003024986-A1 6-O-CARBAMATE-11,12-LACTO-KETOLIDE ANTIMICROBIALS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-03-27 WO disclosed
US-20030004339-A1 Process for the production of quinazolines PFIZER INC. 2003-01-02 US disclosed
WO-2002094815-A1 PROCESS FOR THE PRODUCTION OF QUINAZOLINES PFIZER LIMITED (GB) 2002-11-28 WO disclosed
CN-1073110-C Process for the preparation of biphenyl derivatives AMERICAN HOME PROD (US) 2001-10-17 CN disclosed
CN-1192214-A Process for the preparation of biphenyl derivatives AMERICAN HOME PROD (US) 1998-09-02 CN disclosed